Tharmalingam N - Search Results

1

Hand Sanitizers: A Review on Formulation Aspects, Adverse Effects, and Regulations.

Jing JLJ, Pei Yi T, Bose RJC, McCarthy JR, Tharmalingam N, Madheswaran T. Jing JLJ, et al. Among authors: tharmalingam n. Int J Environ Res Public Health. 2020 May 11;17(9):3326. doi: 10.3390/ijerph17093326. Int J Environ Res Public Health. 2020. PMID: 32403261 Free PMC article.

2

Reconstructed Apoptotic Bodies as Targeted "Nano Decoys" to Treat Intracellular Bacterial Infections within Macrophages and Cancer Cells.

Bose RJC, Tharmalingam N, Garcia Marques FJ, Sukumar UK, Natarajan A, Zeng Y, Robinson E, Bermudez A, Chang E, Habte F, Pitteri SJ, McCarthy JR, Gambhir SS, Massoud TF, Mylonakis E, Paulmurugan R. Bose RJC, et al. Among authors: tharmalingam n. ACS Nano. 2020 May 26;14(5):5818-5835. doi: 10.1021/acsnano.0c00921. Epub 2020 May 4. ACS Nano. 2020. PMID: 32347709 Free PMC article.

3

Labeling and tracking cells with gold nanoparticles.

Chandrasekaran R, Madheswaran T, Tharmalingam N, Bose RJ, Park H, Ha DH. Chandrasekaran R, et al. Among authors: tharmalingam n. Drug Discov Today. 2021 Jan;26(1):94-105. doi: 10.1016/j.drudis.2020.10.020. Epub 2020 Oct 31. Drug Discov Today. 2021. PMID: 33130336 Review.

4

Combating Intracellular Pathogens with Nanohybrid-Facilitated Antibiotic Delivery.

Bose RJC, Tharmalingam N, Choi Y, Madheswaran T, Paulmurugan R, McCarthy JR, Lee SH, Park H. Bose RJC, et al. Among authors: tharmalingam n. Int J Nanomedicine. 2020 Oct 29;15:8437-8449. doi: 10.2147/IJN.S271850. eCollection 2020. Int J Nanomedicine. 2020. PMID: 33162754 Free PMC article.

5

Bacterial cancer therapy: A turning point for new paradigms.

Mayakrishnan V, Kannappan P, Tharmalingam N, Bose RJC, Madheswaran T, Ramasamy M. Mayakrishnan V, et al. Among authors: tharmalingam n. Drug Discov Today. 2022 Aug;27(8):2043-2050. doi: 10.1016/j.drudis.2022.03.007. Epub 2022 Mar 15. Drug Discov Today. 2022. PMID: 35304339

6

First report of mecC gene in clinical methicillin resistant S. aureus (MRSA) from tertiary care hospital Islamabad, Pakistan.

Khan AA, Ali A, Tharmalingam N, Mylonakis E, Zahra R. Khan AA, et al. Among authors: tharmalingam n. J Infect Public Health. 2020 Oct;13(10):1501-1507. doi: 10.1016/j.jiph.2020.05.017. Epub 2020 Jun 6. J Infect Public Health. 2020. PMID: 32517997 Free article.

7

Repurposing niclosamide as a versatile antimicrobial surface coating against device-associated, hospital-acquired bacterial infections.

Gwisai T, Hollingsworth NR, Cowles S, Tharmalingam N, Mylonakis E, Fuchs BB, Shukla A. Gwisai T, et al. Among authors: tharmalingam n. Biomed Mater. 2017 Jul 12;12(4):045010. doi: 10.1088/1748-605X/aa7105. Biomed Mater. 2017. PMID: 28471351 Free PMC article.

8

Repurposing the anthelmintic drug niclosamide to combat Helicobacter pylori.

Tharmalingam N, Port J, Castillo D, Mylonakis E. Tharmalingam N, et al. Sci Rep. 2018 Feb 27;8(1):3701. doi: 10.1038/s41598-018-22037-x. Sci Rep. 2018. PMID: 29487357 Free PMC article.

9

Vulnerability of long-term care facility residents to Clostridium difficile infection due to microbiome disruptions.

Fuchs BB, Tharmalingam N, Mylonakis E. Fuchs BB, et al. Among authors: tharmalingam n. Future Microbiol. 2018 Oct;13:1537-1547. doi: 10.2217/fmb-2018-0157. Epub 2018 Oct 12. Future Microbiol. 2018. PMID: 30311778 Review.

10

The Anti-virulence Efficacy of 4-(1,3-Dimethyl-2,3-Dihydro-1H-Benzimidazol-2-yl)Phenol Against Methicillin-Resistant Staphylococcus aureus.

Tharmalingam N, Khader R, Fuchs BB, Mylonakis E. Tharmalingam N, et al. Front Microbiol. 2019 Jul 17;10:1557. doi: 10.3389/fmicb.2019.01557. eCollection 2019. Front Microbiol. 2019. PMID: 31379761 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page